During a routine long-term drug safety study, lasting approximately 2½ yr, male Wistar rats, treated with a prolactin-inhibiting compound, developed an excess of Leydig cell tumors (LCTs). Most tumors were typical for the rat but a small number showed an unusual variation and some appeared malignant. The variation consisted of glandular and/or tubular structures within the tumor mass which occasionally anastomosed and contained an eosinophilic periodic-acid Schiff (PAS) positive material. In a few of these variants, malignant features such as cellular atypia, capsular, and lymphatic invasion and necrosis were seen. No metastases were detected. Detailed morphological and immunohistochemical investigations were conducted in order to establish the cell of origin of these variants. Glandular/tubular structures were found to stain with varying intensity for vimentin and cytokeratin, but were always negative for β-tubulin. The results indicated that the cell of origin of these LCT variants was indeed the Leydig cell and that glandular and/or tubular structures within LCTs represented a form of Leydig cell metaplasia.
1. Franke WW, Winter S, Overbeck J, Gudat F, Heitz PU, and Stähli C (1987). Identification of the conserved, conformation-dependent cytokeratin epitope recognized by monoclonal antibody (lu-5). Virchows Arch. A [Pathol. Anat.]411: 137–147.
2.
2. Franke WW, Grand C, and Schmid E (1979). Intermediate-sized filaments present in Sertoli cells are of the vimentin type. Eur. J. Cell Biol.19: 269–275.
3.
3. Frankfurter A, Binden LI, and Rebhun LI (1986). Limited tissue distribution of a novel β-tubulin iso-form. J. Cell Biol.103: 273a (Abstract).
4.
4. Goodman DG, Ward JM, Squire RA, Chu KC, and Linhart MS (1979). Neoplastic and nonneoplastic lesions in aging F344 rats. Toxicol. Appl. Pharmacol.48: 237–248.
5.
5. Gould VE (1987). Synaptophysin. A new and promising pan-neuroendocrine marker. Arch. Pathol. Lab. Med.111: 791–794.
6.
6. Haseman JK, Huff J, and Boorman GA (1984). Use of historical control data in carcinogenicity studies in rodents. Toxicol. Pathol.12: 126–135.
7.
7. Isaka H (1951). On the experimental testicular tumor produced with copper sulfate locally injected in the rat. (Preliminary report.)Gann42: 351–352.
8.
8. Kanno J, Matsuoka C, Furuta K, Onodera H, Mae-kawa A, and Hayashi Y (1987). Glandular changes associated with the spontaneous interstitial cell tumor of the rat testes. Toxicol. Pathol.15: 439–443.
9.
9. Lee M, Tuttle JB, and Frankfurter A (1987). Pattern of expression of neuron-specific β-tubulin in early developmental stages of the chick embryo. Neuro-science13: 701 (Abstract).
10.
10. Maekawa A and Hayashi Y (1987). Adenomatous hyperplasia, rete-testis, rat. In: ILSI Monographs on Pathology of Laboratory Animals: Genital System, TC Jones, U Mohr, and RD Hunt (eds). Springer-Verlag, Berlin, pp. 234–236.
11.
11. Miettinen M (1987). Synaptophysin and neurofilament proteins as markers for neuroendocrine tumors. Arch. Pathol. Lab. Med.111: 813–818.
12.
12. Mitsumori K and Elwell MR (1988). Proliferative lesions in the male reproductive system of F344 rats and B6C3F1 mice: Incidence and classification. Environ. Health Perspect.77: 11–21.
13.
13. Mørk SJ, Rubinstein LJ, and Kepes JJ (1988). Patterns of epithelial metaplasia in malignant gliomas. I. Papillary formations mimicking meduIIoepithe-lioma. J. Neuropathol. Exp. Neurol.47: 93–100.
14.
14. Mork SJ, Rubinstein LJ, Kepes JJ, Perentes E, and Uphoff DF (1988). Patterns of epithelial metaplasia in malignant gliomas. II. Squamous differentiation of epithelial-like formations in gliosarcomas and glioblastomas. J. Neuropathol. Exp. Neurol.47: 101–118.
15.
15. Mostofi FK and Bresler VM (1976). Tumors of the testis. In: Pathology of Tumors in Laboratory Animals, VS Turusov (ed). International Agency for Research on Cancer, Lyon, pp. 135–150.
16.
16. Patnaik AK, Saigo PE, Liberman PH, and Greenlee PG (1988). Morphology of canine ovarian Sertoli-Leydig cell neoplasms. Cancer62: 577–584.
17.
17. Perentes E and Rubinstein LJ (1985). Immunohis-tochemical recognition of human nerve sheath tumors by anti-Leu 7 monoclonal antibody. Acta Neuropathol. (Berl.)68: 319–324.
18.
18. Perentes E and Rubinstein LJ (1987). Recent applications of immunoperoxidase histochemistry in human neuro-oncology. An update. Arch. Pathol. Lab. Med.111: 796–812.
19.
19. Ramaekers F, Feitz W, Moesker O, Schaart G, Herman C, Debruyne F, and Vooijs P (1985). Antibodies to cytokeratin and vimentin in testicular tumor diagnosis.Virchows Arch. A [Pathol. Anat.]408: 127–142.
20.
20. Rehm S and Waalkes MP (1988). Mixed Sertoli-Ley-dig cell tumor and rete testis adenocarcinoma in rats treated with CdCl2-Vet. Pathol.25: 163–166.
21.
21. Roe FJC, Dukes CE, Cameron KM, Pugh RCB, and Mitchley BCV (1964). Cadmium neoplasia: Testicular atrophy and Leydig cell hyperplasia and neoplasia in rats and mice following the subcutaneous injection of cadmium salts. Br. J. Cancer18: 674–681.
22.
22. Roth LM, Slayton RE, Brady LW, Blessing JA, and Johnson G (1985). Retiform differentiation in ovarian Sertoli-Leydig cell tumors. Cancer55: 1093–1098.
23.
23. Schulze W, Davidoff MS, and Holstein A-F (1987). Are Leydig cells of neural origin? Substance P-like immunoreactivity in human testicular tissue. Acta Endocrinol. (Copenh.)115: 373–377.
24.
24. Schulze W, Davidoff MS, Holstein A-F, and Schirren C (1987). Processing of testicular biopsies—fixed in Stieve's solution—for visualization of substance P-and methionine-enkephalin-like immunoreactivity in Leydig cells. Andrologia19: 419–422.
25.
25. Scully RE (1982). Sex cord stromal tumors. In: Pathology of the Female Genital Tract, 2nd ed., A Blaustein (ed). Springer-Verlag, New York, pp. 505–526.
26.
26. Snell KC (1965). Spontaneous lesions of the rat. In: The Pathology of Laboratory Animals, WE Ribelin and JR McCoy (eds). Charles C. Thomas, Springfield, Illinois, pp. 266–268.
27.
27. Sporrong B, Clase L, Ljungberg O, and Wadstein C (1982). Neurohormonal peptides and argyrophil cells in an androblastoma of the ovary. Virchows Arch. A [Pathol. Anat.]396: 239–246.
28.
28. Sternberger LA, Hardy PH Jr, Cuculis JJ, and Meyer HG (1970). The unlabeled antibody enzyme method of immunohistochemistry. Preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J. Histochem. Cyto-chem.18: 315–333.
29.
29. Sullivan KF and Cleveland DW (1986). Identification of conserved isotype-defining variable region sequences for four vertebrate β-tubulin polypeptide classes. Proc. Natl. Acad. Sci. USA83: 4327–4331.
30.
30. Sweeney EC, Barry-Walsh C, and Robinson A (1983). Sertoli-Leydig cell tumor of the ovary with heterologous elements and carcinoma: An immunohisto-chemical and ultrastructural study. Ultrastruct. Pathol.5: 185–194.
31.
31. Talerman A (1987). Ovarian Sertoli-Leydig cell tumor (androblastoma) with retiform pattern. Cancer60: 3056–3064.
32.
32. van Vorstenbosch CJAHV, Colenbrander B, Wensing CJG, Ramaekers FCS, and Vooijs GP (1984). Cytoplasmic filaments in fetal and neonatal pig testis. Eur. J. Cell Biol.34: 292–299.
33.
33. Ueda G, Yamasaki M, Inoue M, Tanaka Y, Inoue Y, Nishino T, Saito J, and Tanizawa O (1985). Expression of cytokeratins in Sertoli-Leydig cell tumors of the ovary. Acta Obst. Gynaec. Jpn.37: 1937–1938.
34.
34. Waxman M, Damjanev I, Alpert L, and Sardinsky T (1981). Composite mucinous ovarian neoplasms associated with Sertoli-Leydig cell and carcinoid tumors. Cancer47: 2044–2052.
35.
35. Young RH, Prat J, and Scully RE (1982). Ovarian Sertoli-Leydig cell tumor with heterologous elements. I. Gastrointestinal epithelium and carcinoid: A clin-icopathological analysis of thirty-six cases. Cancer50: 2448–2456.
36.
36. Young RH and Scully RE (1983). Ovarian Sertoli-Leydig cell tumors with a retiform pattern: A problem in histopathologic diagnosis. Am. J. Surg. Pathol.7: 755–771.
